<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Phil</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Denson, Joshua L.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Successful Combination Therapies, Hospital Utilization Improvements among Late-Breaking Clinical Trials</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-12-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">8-10</style></pages><abstract><style  face="normal" font="default" size="100%">This article reviews multiple late-breaking clinical trials focusing on combination therapy and hospital utilization improvements. Specific trials include the phase 3 AMBITION [NCT01178073], the Comprehensive Respiratory Outcome Management program, as well as trials investigating the use of noninvasive open ventilation, end-of-rotation handoffs, and 2 phase 3 randomized controlled studies [NCT01957163; NCT02119286] looking at umeclidinium for the treatment of COPD.</style></abstract><number><style face="normal" font="default" size="100%">45</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>